Abstral Sublingual Tablets: Rapid Relief for Breakthrough Cancer Pain
Abstral Sublingual Tablets represent a breakthrough in pain management technology, offering cancer patients fast-acting relief when they need it most. These innovative sublingual tablets are specifically designed for opioid-tolerant adults experiencing breakthrough cancer pain.
Fast-Acting Technology
Abstral utilizes advanced sublingual delivery that dissolves rapidly under the tongue, bypassing the digestive system for:
-
Quick onset – Pain relief begins within minutes
-
Predictable absorption – Consistent medication delivery
-
Convenient administration – No water needed, discrete usage
Precise Dosing Options
Available in multiple strengths (100mcg, 200mcg, 300mcg, 400mcg, 600mcg, 800mcg) to allow healthcare providers to:
-
Customize treatment to individual patient needs
-
Titrate effectively for optimal pain control
-
Minimize side effects through proper dosing
Patient-Focused Benefits
-
Rapid relief when breakthrough pain strikes
-
Proven efficacy in clinical studies
-
Quality of life improvement through better pain management
-
Trusted solution prescribed by pain specialists worldwide
Important Safety Information
Abstral contains fentanyl, a potent opioid medication requiring careful management:
-
For opioid-tolerant patients only
-
Must be prescribed by certified healthcare providers
-
Requires patient education on proper usage
-
Regular monitoring essential for safe continued use
Why Healthcare Providers Choose Abstral
-
Proven track record in breakthrough cancer pain management
-
Flexible dosing options for personalized care
-
Rapid action when patients need relief most
-
Comprehensive support programs available







Reviews
There are no reviews yet.